ProCure screening increases self-storage demand, benefits Public Storage (PSA)

Health outreach at proton therapy center reshapes local self-storage needs

ProCure Proton Therapy Center in Somerset, N.J., is launching a high-profile PSA screening push that is reshaping nearby demand for short-term and specialized storage services, industry sources and local commercial managers say. The center’s “Relax Your Tight End” campaign, timed to National Cancer Prevention Month, encourages men to use PSA blood tests and is expected to increase diagnostic visits and treatment planning appointments at the tri-state facility. For self-storage operators such as Public Storage, which owns facilities throughout the region, those patient flows translate into predictable demand for temporary and climate-controlled units from out-of-town families, patients relocating for care, and households preparing homes for extended treatment-related absences.

Healthcare-driven mobility is emerging as a subtle but growing driver of occupancy patterns for self-storage providers, particularly near specialized cancer centers with regional draw. ProCure’s Somerset facility, which opened in 2012 and has treated more than 7,500 patients including over 750 pediatric cases, regularly attracts domestic and international patients who need short leases, flexible access and secure space for medical equipment, medical records, or household goods. Public Storage and peers can respond with targeted offerings — short-term promotions, move-in assistance, and units suited to medical equipment — to capture near-term spikes tied to screening campaigns and treatment cycles without disrupting long-term tenancy profiles.

Industry executives say partnerships between medical centers and nearby storage operators are straightforward to implement and can improve patient logistics while supporting revenue diversification for real estate owners. Simple initiatives — preferred rates for patients, information shared at clinic intake, or a designated contact for families — reduce friction for patients and can increase unit turnover efficiency for operators. As precision therapies such as proton therapy reduce overall treatment downtime but still require localized stays, the alignment between cancer centers’ outreach and storage demand is likely to persist.

Campaign and clinical messaging

ProCure is using humor and NFL-themed creative to reduce stigma around prostate screening, emphasizing that PSA blood tests detect cancer early and allow for treatment choices that preserve quality of life, Medical Director Brian Chon, M.D., says.

Proton therapy positioning

ProCure promotes proton therapy as a precise, non-surgical option that minimizes radiation to surrounding tissue, and notes its Somerset center’s decade-plus regional role in offering personalized treatments.